Inventor · disambiguated record
David Mark Wallace
Also filed as: WALLACE DAVID · WALLACE DAVID M · WALLACE DAVID MARK
112 granted patents·13 pending applications·2,516 citations·filing 2001–2023
99Inventor score
Files withSAMUMED LLC88CHUGAI PHARMACEUTICAL CO LTD9BIOSPLICE THERAPEUTICS INC7TACHDJIAN CATHERINE4FIRMENICH INCORPORATED3
Top patents by PatentIndex Score
125 records- 0199US9844536B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Dec 19, 2017·49 cites·37 claims
- 0299US9828372B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 28, 2017·49 cites·36 claims
- 0399US9763951B23-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·36 claims
- 0499US9763927B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·26 claims
- 0599US9586977B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Mar 7, 2017·49 cites·22 claims
- 0699US9381192B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jul 5, 2016·49 cites·47 claims
- 0799US9233104B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 12, 2016·67 cites·28 claims
- 0899US9199991B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Dec 1, 2015·70 cites·38 claims
- 0999US8987298B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 24, 2015·77 cites·79 claims
- 1099US8901150B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Dec 2, 2014·77 cites·30 claims
- 1199US8703794B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Apr 22, 2014·81 cites·20 claims
- 1299US8673936B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 18, 2014·85 cites·28 claims
- 1399US8664241B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 4, 2014·83 cites·30 claims
- 1499US8618128B11H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 31, 2013·84 cites·30 claims
- 1599US8604052B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 10, 2013·92 cites·18 claims
- 1698US10407425B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2018·Granted Sep 10, 2019·15 cites·18 claims
- 1798US9889140B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Feb 13, 2018·23 cites·36 claims
- 1898US9855272B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jan 2, 2018·44 cites·17 claims
- 1998US9815854B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 14, 2017·49 cites·37 claims
- 2098US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 2198US9540398B23-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 10, 2017·33 cites·32 claims
- 2298US9090613B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jul 28, 2015·84 cites·23 claims
- 2398US9067939B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jun 30, 2015·75 cites·18 claims
- 2498US9012472B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Apr 21, 2015·73 cites·77 claims
- 2598US8883822B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Nov 11, 2014·76 cites·16 claims
- 2698US8846714B21H-pyrazolo[3,4-β]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Sep 30, 2014·82 cites·32 claims
- 2798US8822478B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofHOOD JOHN·Filed 2012·Granted Sep 2, 2014·79 cites·65 claims
- 2898US8450340B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofHOOD JOHN·Filed 2010·Granted May 28, 2013·132 cites·22 claims
- 2998US8252812B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofHOOD JOHN·Filed 2010·Granted Aug 28, 2012·93 cites·24 claims
- 3097US11697649B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jul 11, 2023·3 cites·31 claims
- 3197US10947228B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·9 cites·36 claims
- 3297US10131677B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2017·Granted Nov 20, 2018·15 cites·32 claims
- 3397US8968708B2Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositionsTACHDJIAN CATHERINE·Filed 2006·Granted Mar 3, 2015·108 cites·60 claims
- 3497US8124121B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofTACHDJIAN CATHERINE·Filed 2008·Granted Feb 28, 2012·93 cites·7 claims
- 3596US9994563B2Indazole inhibitors of the wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jun 12, 2018·7 cites·5 claims
- 3695US11560378B2Treatment of osteoarthritisBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·3 cites·8 claims
- 3795US8895050B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofTACHDJIAN CATHERINE·Filed 2011·Granted Nov 25, 2014·12 cites·16 claims
- 3895US8784782B2Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositionsTACHDJIAN CATHERINE·Filed 2012·Granted Jul 22, 2014·27 cites·27 claims
- 3995US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
- 4095US7622614B2Methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro [4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-oneALLYLIX INC·Filed 2008·Granted Nov 24, 2009·23 cites·57 claims
- 4194US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
- 4294US8815897B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Aug 26, 2014·82 cites·65 claims
- 4394US8362309B2Fragrance and methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-oneALLYLIX INC·Filed 2012·Granted Jan 29, 2013·9 cites·17 claims
- 4493US9884053B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Feb 6, 2018·7 cites·42 claims
- 4593US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
- 4692US11667632B22-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jun 6, 2023·2 cites·8 claims
- 4792US8609717B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsKC SUNIL KUMAR·Filed 2011·Granted Dec 17, 2013·17 cites·16 claims
- 4891US9738638B22-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Aug 22, 2017·4 cites·31 claims
- 4991US9493437B2β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 5091US9493487B23-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Nov 15, 2016·4 cites·31 claims
Showing the top 50 of 125 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →